Reckitt Benckiser (LON:RB) sales grew by 2 percent in the last quarter, falling shy of the 2.8 percent growth estimated by analysts.

The health, hygiene, and home products producer put the miss down to “flagged issues in Korea, Russia and our Scholl innovation.”

Reckitt Benckiser suffered a large exceptional charge in first half earnings tied to deaths in South Korea from 2001 to 2011 related to their humidifier disinfectant.

After updating the market in July to expect like-for-like sales growth to be towards the lower end of the previously stated 4 percent to 5 percent it gave in February, today it has advised they are aiming for 4 percent.

Shares in the company are currently trading down 2.62 percent on the news, at 7,135 (1325GMT).

Previous articleIs Clinton really the ‘safer bet’ for the financial markets?
Next articleApple supplier Laird PLC nose dives on profit warning
Avatar photo
This is the profile of the UK Investor Magazine team who, in collaboration with each other and our partners, produce a number of in-depth analytical articles, reviews of investment services and publish sponsored articles from carefully selected partners.